Back

Initiation of PCSK9 inhibition in patients with heterozygous familial hypercholesterolaemia entering adulthood: a new design for living with a high-risk condition?

European Heart Journal

6 February 2016
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Effectiveness of PCSK9 inhibitors in homozygous familial hypercholesterolemia: insights from a Saudi Arabia genetic population
3 April 2025
thumbnail
Webinar
Update of the 2019 ESC Guidelines on Management of Dyslipidaemia: new recommendations and their impact on clinical practice
25 November 2025
thumbnail
Congress Presentation
Real-world prediagnosis lipid management in parents identified through child-initiated reverse cascade screening for familial hypercholesterolaemia
30 August 2026
thumbnail
Congress Session
Multi-disciplinary approaches to lipid management
24 June 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources